NGL Fine Chem confirms outcome of September 16 virtual analyst meet
- NGL Fine Chem completed its virtual one-to-one analyst meet on September 16, 2026
- No unpublished price-sensitive information was shared during the session
- Only publicly available information was discussed with the analyst
- The disclosure was filed with BSE and NSE under SEBI Regulation 30

*this image is generated using AI for illustrative purposes only.
NGL Fine Chem confirmed the conclusion of its scheduled virtual one-to-one meeting with an analyst on September 16, 2026. The company disclosed that the session proceeded as planned without any presentation or sharing of unpublished price-sensitive information.
The disclosure was filed with both the BSE Limited and the National Stock Exchange of India Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This filing serves as the official outcome report for the engagement previously intimated on September 10, 2026.
Meeting Outcome
The company clarified that only information already available in the public domain was discussed during the interaction. No new financial data or strategic updates were released during the call.
| Parameter | Detail |
|---|---|
| Date | September 16, 2026 |
| Type | One-to-one |
| Mode | Virtual |
| Presentation | None |
Compliance Notes
Shivam Gharat, Company Secretary and Compliance Officer, signed the disclosure dated September 16, 2026. He reaffirmed that no Unpublished Price Sensitive Information (UPSI) pertaining to the company was shared with the analysts or investors during the meet.
Historical Stock Returns for NGL Fine Chem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.50% | +3.31% | +3.93% | +42.14% | +108.05% | +56.45% |
How might the lack of new strategic disclosures during this analyst meeting influence short-term investor sentiment and stock volatility for NGL Fine Chem?
Given the routine nature of this engagement, when is the company expected to release its next quarterly financial results or provide a formal management commentary on operational performance?
Are there any upcoming regulatory filings or board meetings scheduled that could signal potential shifts in NGL Fine Chem's strategic direction or capital allocation plans?


































